Leading AI-Powered Imaging Application Development is the leader in radiology AI applications, using cutting-edge advances in medical imaging to revolutionize disease screening and early detection so patients can enjoy longer, healthier lives. The company develops and markets breakthrough medical device software that quantifies and tracks neurodegenerative diseases and assists in the detection of clinically significant cancer.’s industry-leading brain imaging analysis provides radiologists, neurologists, oncologists, and clinical researchers worldwide with a convenient and cost-effective means to quantify brain structures to help assess neurological conditions, such as Alzheimer’s disease, epilepsy, multiple sclerosis, brain trauma, and brain development abnormalities. The company has FDA-cleared products for use in the diagnosis and follow up of neurodegenerative and traumatic brain conditions, as well as prostate cancer.

See’s leadership team

Sophisticated. Accurate. Fully Automated.

Enhance diagnostics & elevate care and with advanced datasets, accelerated analyses, and more profound insights.

  • CONFIDENTLY ASSESS individual, regional, and global brain structure volumes
  • SAVE TIME by relying on accurate image analysis
  • IMPROVE PATIENT CARE by quickly identifying the areas of most interest/concern
  • REDUCE COSTS with fully automated MRI quantification

Our Mission

To improve patient outcomes by empowering physicians to make more accurate and timely diagnostic decisions, combining cutting edge medical imaging with machine learning and clinical information to develop tools that better predict and diagnose disease.

Quantifying for 15 years


Number of patients processed


Sites installed


Countries installed